1-ethyl-2-methyl-3-hydroxypyridin-4-one has been researched along with 1-methyl-2-ethyl-3-hydroxypyridin-4-one in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| el-Jammal, A; Howell, PL; Li, N; Templeton, DM; Turner, MA | 1 |
| Dobbin, PS; Hall, AD; Hider, RC; Porter, JB; Sarpong, P; Taylor, PD; van der Helm, D; Xiao, G | 1 |
| Dekhordi, LS; Hider, RC; Jin, Y; Khodr, H; Liu, Z; Rai, BL | 1 |
| Hider, RC; Kayyali, R; Liu, ZD; Porter, JB; Theobald, AE | 1 |
| Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT | 1 |
| Caisová, D; Eybl, V; Kontoghiorghes, GJ; Koutenský, J | 1 |
6 other study(ies) available for 1-ethyl-2-methyl-3-hydroxypyridin-4-one and 1-methyl-2-ethyl-3-hydroxypyridin-4-one
| Article | Year |
|---|---|
Copper complexation by 3-hydroxypyridin-4-one iron chelators: structural and iron competition studies.
Topics: Antithyroid Agents; Copper; Deferiprone; Iron Chelating Agents; Ligands; Potentiometry; Pyridones; Spectrophotometry | 1994 |
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship | 1993 |
Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
Topics: Animals; Bile; Ferritins; Iron; Iron Chelating Agents; Male; Molecular Conformation; Pyridones; Rats; Rats, Inbred F344; Solutions; Structure-Activity Relationship | 1998 |
Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.
Topics: Animals; Arachidonate 5-Lipoxygenase; Enzyme Inhibitors; Iron; Iron Chelating Agents; Lipoxygenase Inhibitors; Male; Pyridines; Pyridones; Rats; Rats, Wistar; Structure-Activity Relationship | 2002 |
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc | 2011 |
Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.
Topics: Animals; Cadmium; Carbon Tetrachloride; Deferiprone; Glutathione; In Vitro Techniques; Indium; Iron; Iron Chelating Agents; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Pyridones | 1991 |